학술논문
Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models
Document Type
Article
Author
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, 1 March 2024, 23(3):257-271)
Subject
Language
English
ISSN
15388514
15357163
15357163